Condition: Tetraplegia/Tetraparesis · Quadriplegia · Quadriplegia/Tetraplegia · Sponsor: Neuralink Corp
The GB-PRIME Study is an early feasibility study designed to assess the clinical safety and functionality of the Neuralink N1 Implant and R1 Robot. This study involves participants who have tetraparesis, tetraplegia, or a diagnosis that may lead to these conditions. The N1 Implant is a wireless, rechargeable device mounted on the skull, connected to electrode threads that are inserted into the brain by the R1 Robot, which is a robotic device specifically designed for this procedure.
This description comes directly from the study's public registry record.
Neuralink Clinical Team · (877) 398-4465 · clinical-team-ct@neuralink.com
Always discuss trial participation with your own doctor first.
| University College London Hospitals NHS Foundation Trust | London, Greater London, United Kingdom | Recruiting |
| The Newcastle upon Tyne Hospitals NHS Foundation Trust | Newcastle upon Tyne, Tyne and Wear, United Kingdom | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07127172